Skip Navigation


International Immunology Advance Access originally published online on April 5, 2004
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
16/5/643    most recent
dxh072v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (8)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Tokoyoda, K.
Right arrow Articles by Yamamoto, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tokoyoda, K.
Right arrow Articles by Yamamoto, H.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

International Immunology, Vol. 16, No. 5, pp. 643-653, May 2004
© 2004 Japanese Society for Immunology

Up-regulation of IL-4 production by the activated cAMP/cAMP-dependent protein kinase (protein kinase A) pathway in CD3/CD28-stimulated naive T cells

Koji Tokoyoda1, Kazutake Tsujikawa1, Hiroaki Matsushita1, Yuichi Ono1, Tamon Hayashi1, Yohsuke Harada2, Ryo Abe2, Masato Kubo2 and Hiroshi Yamamoto1

1 Department of Immunology, Graduate School of Pharmaceutical Sciences, Osaka University, 1–6 Yamadaoka, Suita, Osaka 565-0871, Japan 2 Research Institute for Biological Sciences, Tokyo University of Science, 2669 Yamazaki, Noda, Chiba 278-0022, Japan

Correspondence to: K. Tsujikawa; E-mail: tujikawa{at}phs.osaka-u.ac.jp
Transmitting editor: T. Saito

The signal transduction of the cAMP/cAMP-dependent protein kinase [protein kinase A (PKA)] pathway through multiple receptors is critical for many processes in all cell types. In T cells, the engagement of both the TCR–CD3 complex and the CD28 co-stimulatory molecule also induces cAMP, and subsequently activates PKA. It is believed that elevation of cAMP levels in T cells is inhibitory of IL-2 production and T cell proliferation. However, the function and detailed signal transduction mechanisms of the cAMP/PKA pathway in naive Th cells are less well understood. In this study, we show that calcitonin gene-related peptide (CGRP) down-regulates IL-2 and IFN-{gamma} production and up-regulates IL-4 production to promote Th2 differentiation by moderate activation of the cAMP/PKA pathway via the CGRP receptor in the presence of a CD3/CD28 co-stimulation signal. The IL-4 production and transcriptional activation of Th2 cytokine mRNAs were also reproduced by the addition of a cAMP analogue, dibutyryl-cAMP, in CD3/CD28-stimulated naive Th cells. More interestingly, cAMP/PKA activation in naive Th cells stimulated with anti-CD3 plus anti-CD28 mAb is essential for inducing IL-4 production and promoting Th2 differentiation; in addition, NF-AT is a downstream effector of the cAMP/PKA signaling pathway. These findings indicate that the cAMP/PKA pathway transduces the critical activation signal to Th2 polarization by a CD3/CD28 co-stimulation signal and a PKA activating reagent.

Keywords: calcitonin gene-related peptide, NF-AT, Th1, Th2


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J. Biol. Chem.Home page
S. Klein-Hessling, T. Bopp, M. K. Jha, A. Schmidt, S. Miyatake, E. Schmitt, and E. Serfling
Cyclic AMP-induced Chromatin Changes Support the NFATc-mediated Recruitment of GATA-3 to the Interleukin 5 Promoter
J. Biol. Chem., November 7, 2008; 283(45): 31030 - 31037.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
K. Tsujikawa, K. Yayama, T. Hayashi, H. Matsushita, T. Yamaguchi, T. Shigeno, Y. Ogitani, M. Hirayama, T. Kato, S.-i. Fukada, et al.
Hypertension and dysregulated proinflammatory cytokine production in receptor activity-modifying protein 1-deficient mice
PNAS, October 16, 2007; 104(42): 16702 - 16707.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
W. Zhou, T. S. Blackwell, K. Goleniewska, J. F. O'Neal, G. A. FitzGerald, M. Lucitt, R. M. Breyer, and R. S. Peebles Jr.
Prostaglandin I2 analogs inhibit Th1 and Th2 effector cytokine production by CD4 T cells
J. Leukoc. Biol., March 1, 2007; 81(3): 809 - 817.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
V. B. Cismasiu, S. Ghanta, J. Duque, D. I. Albu, H.-M. Chen, R. Kasturi, and D. Avram
BCL11B participates in the activation of IL2 gene expression in CD4+ T lymphocytes
Blood, October 15, 2006; 108(8): 2695 - 2702.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
S. Ryzhov, A. E. Goldstein, I. Biaggioni, and I. Feoktistov
Cross-Talk between Gs- and Gq-Coupled Pathways in Regulation of Interleukin-4 by A2B Adenosine Receptors in Human Mast Cells
Mol. Pharmacol., August 1, 2006; 70(2): 727 - 735.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
A. Nirula, M. Ho, H. Phee, J. Roose, and A. Weiss
Phosphoinositide-dependent kinase 1 targets protein kinase A in a pathway that regulates interleukin 4
J. Exp. Med., July 10, 2006; 203(7): 1733 - 1744.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.